Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 12:41 pm Purchase | 2024-09-30 | 13G | Guided Therapeutics, Inc. GTHP | Auctus Fund Management LLC | 5,804,865 9.900% | 462,025 (+8.65%) | Filing History |
| 2024-02-20 1:42 pm Sale | 2023-12-31 | 13G | Guided Therapeutics, Inc. GTHP | Rosalind Advisors Inc. | 0 0.000% | -2,338,740 (Position Closed) | Filing History |
| 2024-02-14 1:48 pm Purchase | 2023-12-31 | 13G | Guided Therapeutics, Inc. GTHP | Auctus Fund Management LLC | 5,342,840 9.900% | 397,043 (+8.03%) | Filing History |
| 2023-02-14 12:54 pm Purchase | 2022-12-31 | 13G | Guided Therapeutics, Inc. GTHP | Auctus Fund Management LLC | 4,945,797 9.900% | 190,699 (+4.01%) | Filing History |
| 2022-10-24 4:17 pm Purchase | 2022-10-11 | 13G | Guided Therapeutics, Inc. GTHP | Auctus Fund Management LLC | 4,755,098 9.900% | 4,755,098 (New Position) | Filing History |
| 2022-07-06 4:34 pm Purchase | 2022-06-22 | 13G | Guided Therapeutics, Inc. GTHP | Rosalind Advisors Inc. | 2,338,740 8.300% | 2,338,740 (New Position) | Filing History |